Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
8.68
-0.36 (-3.98%)
At close: Nov 20, 2026, 4:00 PM EST
8.80
+0.12 (1.38%)
After-hours: Nov 20, 2026, 7:30 PM EST
Contineum Therapeutics Employees
Contineum Therapeutics had 51 employees as of December 31, 2025. The number of employees increased by 10 or 24.39% compared to the previous year. That makes Contineum Therapeutics the 34,831st largest employer in the world and 4,629th in the United States.
Employees
51
Change (1Y)
10
Growth (1Y)
24.39%
Revenue / Employee
n/a
Profits / Employee
-$1,244,373
Market Cap
340.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 51 | 10 | 24.39% |
| Dec 31, 2024 | 41 | 10 | 32.26% |
| Dec 31, 2023 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 179 |
| Lyell Immunopharma | 161 |
| MapLight Therapeutics | 133 |
| Inovio Pharmaceuticals | 112 |
| C4 Therapeutics | 104 |
| Alector | 103 |
| Prelude Therapeutics | 79 |
| Larimar Therapeutics | 71 |
CTNM News
- 10 days ago - Contineum Therapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 13 days ago - Qureight's Fibrosis Imaging Biomarker Selected by Contineum Therapeutics as a Secondary Endpoint in Phase 2 PROPEL-IPF Clinical Trial - Business Wire
- 18 days ago - Contineum reports Q3 EPS (49c), consensus (45c) - TheFly
- 18 days ago - Contineum Therapeutics Reports Third-Quarter 2026 Financial Results - Business Wire
- 18 days ago - Contineum Therapeutics Earnings release: Q3 2026 - Filings
- 18 days ago - Contineum Therapeutics Quarterly report: Q3 2026 - Filings
- 19 days ago - Contineum Therapeutics Slides: Corporate presentation - Filings
- 23 days ago - Contineum Therapeutics to Present at the Stifel 2026 Healthcare Conference - Business Wire